These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2056138)

  • 1. A preliminary trial of fluoxetine in refractory borderline patients.
    Cornelius JR; Soloff PH; Perel JM; Ulrich RF
    J Clin Psychopharmacol; 1991 Apr; 11(2):116-20. PubMed ID: 2056138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine trial in borderline personality disorder.
    Cornelius JR; Soloff PH; Perel JM; Ulrich RF
    Psychopharmacol Bull; 1990; 26(1):151-4. PubMed ID: 2371370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine trial in suicidal depressed alcoholics.
    Cornelius JR; Salloum IM; Cornelius MD; Perel JM; Thase ME; Ehler JG; Mann JJ
    Psychopharmacol Bull; 1993; 29(2):195-9. PubMed ID: 8290665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the suicidal behavior of adolescent inpatients with borderline personality disorder and major depression.
    Horesh N; Orbach I; Gothelf D; Efrati M; Apter A
    J Nerv Ment Dis; 2003 Sep; 191(9):582-8. PubMed ID: 14504567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-lethality status in patients with borderline personality disorder.
    Soloff PH; Fabio A; Kelly TM; Malone KM; Mann JJ
    J Pers Disord; 2005 Aug; 19(4):386-99. PubMed ID: 16178681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venlafaxine in the treatment of borderline personality disorder.
    Markovitz PJ; Wagner SC
    Psychopharmacol Bull; 1995; 31(4):773-7. PubMed ID: 8851652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.
    Zanarini MC; Frankenburg FR; Parachini EA
    J Clin Psychiatry; 2004 Jul; 65(7):903-7. PubMed ID: 15291677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open trial of valproate in borderline personality disorder.
    Stein DJ; Simeon D; Frenkel M; Islam MN; Hollander E
    J Clin Psychiatry; 1995 Nov; 56(11):506-10. PubMed ID: 7592502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Borderline personality, impulsiveness, and platelet monoamine measures in bulimia nervosa and recurrent suicidal behavior.
    Verkes RJ; Pijl H; Meinders AE; Van Kempen GM
    Biol Psychiatry; 1996 Aug; 40(3):173-80. PubMed ID: 8830950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Symptom-focussed drug therapy in borderline personality disorder].
    Schmahl C; Bohus M
    Fortschr Neurol Psychiatr; 2001 Jul; 69(7):310-21. PubMed ID: 11488246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Symptoms of DSM IV borderline personality disorder in a nonclinical population of adolescents: study of a series of 35 patients].
    Chabrol H; Chouicha K; Montovany A; Callahan S
    Encephale; 2001; 27(2):120-7. PubMed ID: 11407263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine in the treatment of anger: an open clinical trial.
    Rubey RN; Johnson MR; Emmanuel N; Lydiard RB
    J Clin Psychiatry; 1996 Sep; 57(9):398-401. PubMed ID: 9746447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine treatment of impulsive aggression in DSM-III-R personality disorder patients.
    Coccaro EF; Astill JL; Herbert JL; Schut AG
    J Clin Psychopharmacol; 1990 Oct; 10(5):373-5. PubMed ID: 2258454
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychopharmacology of borderline personality disorder: a review.
    Cowdry RW
    J Clin Psychiatry; 1987 Aug; 48 Suppl():15-25. PubMed ID: 2886493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of phenelzine and haloperidol in borderline personality disorder.
    Soloff PH; Cornelius J; George A; Nathan S; Perel JM; Ulrich RF
    Arch Gen Psychiatry; 1993 May; 50(5):377-85. PubMed ID: 8489326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affective instability as rapid cycling: theoretical and clinical implications for borderline personality and bipolar spectrum disorders.
    Mackinnon DF; Pies R
    Bipolar Disord; 2006 Feb; 8(1):1-14. PubMed ID: 16411976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder.
    Chouinard G
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):32-7. PubMed ID: 3882679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What constitutes an adequate antidepressant trial for fluoxetine?
    Schweizer E; Rickels K; Amsterdam JD; Fox I; Puzzuoli G; Weise C
    J Clin Psychiatry; 1990 Jan; 51(1):8-11. PubMed ID: 2403998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
    Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reexposure to fluoxetine after serious suicide attempts by three patients: the role of akathisia.
    Rothschild AJ; Locke CA
    J Clin Psychiatry; 1991 Dec; 52(12):491-3. PubMed ID: 1752848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.